ITMI991625A0 - Formulazioni ottimizzate costituite da soluzioni di steroidi da sommin istrare per inalazione - Google Patents

Formulazioni ottimizzate costituite da soluzioni di steroidi da sommin istrare per inalazione

Info

Publication number
ITMI991625A0
ITMI991625A0 IT99MI001625A ITMI991625A ITMI991625A0 IT MI991625 A0 ITMI991625 A0 IT MI991625A0 IT 99MI001625 A IT99MI001625 A IT 99MI001625A IT MI991625 A ITMI991625 A IT MI991625A IT MI991625 A0 ITMI991625 A0 IT MI991625A0
Authority
IT
Italy
Prior art keywords
inhalation
administered
formulations made
optimized formulations
steroid solutions
Prior art date
Application number
IT99MI001625A
Other languages
English (en)
Inventor
Chiara Malvolti
Raffaella Garzia
Gaetano Brambilla
Paolo Chiesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ITMI991625A0 publication Critical patent/ITMI991625A0/it
Priority to IT1999MI001625A priority Critical patent/IT1313553B1/it
Priority to SI200030152T priority patent/SI1198224T1/xx
Priority to PCT/EP2000/006916 priority patent/WO2001007014A1/en
Priority to PT00956216T priority patent/PT1198224E/pt
Priority to EP00956216A priority patent/EP1198224B1/en
Priority to DE60003183T priority patent/DE60003183T2/de
Priority to DK00956216T priority patent/DK1198224T3/da
Priority to ES00956216T priority patent/ES2200913T3/es
Priority to PL353470A priority patent/PL198817B1/pl
Priority to US10/030,101 priority patent/US6967017B1/en
Priority to AT00956216T priority patent/ATE241959T1/de
Priority to CZ20020257A priority patent/CZ299071B6/cs
Priority to AU68250/00A priority patent/AU6825000A/en
Priority to HU0201956A priority patent/HUP0201956A3/hu
Publication of ITMI991625A1 publication Critical patent/ITMI991625A1/it
Priority to NO20020342A priority patent/NO20020342L/no
Application granted granted Critical
Publication of IT1313553B1 publication Critical patent/IT1313553B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
IT1999MI001625A 1999-07-23 1999-07-23 Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. IT1313553B1 (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IT1999MI001625A IT1313553B1 (it) 1999-07-23 1999-07-23 Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
PL353470A PL198817B1 (pl) 1999-07-23 2000-07-20 Preparaty roztworów steroidów do podawania wziewnego i sposób wytwarzania i sposób wytwarzania tych preparatów
AT00956216T ATE241959T1 (de) 1999-07-23 2000-07-20 Formulierungen von steroidlösungen zur inhalativen verabreichung
PT00956216T PT1198224E (pt) 1999-07-23 2000-07-20 Formulacoes de solucoes de esteroides para administracao por inalacao
EP00956216A EP1198224B1 (en) 1999-07-23 2000-07-20 Formulations of steroid solutions for inhalatory administration
DE60003183T DE60003183T2 (de) 1999-07-23 2000-07-20 Formulierungen von steroidlösungen zur inhalativen verabreichung
DK00956216T DK1198224T3 (da) 1999-07-23 2000-07-20 Formuleringer til opløsninger af steroider til indgivelse via inhalering
ES00956216T ES2200913T3 (es) 1999-07-23 2000-07-20 Formulaciones de soluciones esteroides para administracion por inhalacion.
SI200030152T SI1198224T1 (en) 1999-07-23 2000-07-20 Formulations of steroid solutions for inhalatory administration
US10/030,101 US6967017B1 (en) 1999-07-23 2000-07-20 Formulations of steroid solutions for inhalatory administration
PCT/EP2000/006916 WO2001007014A1 (en) 1999-07-23 2000-07-20 Formulations of steroid solutions for inhalatory administration
CZ20020257A CZ299071B6 (cs) 1999-07-23 2000-07-20 Stálý farmaceutický steroidní prostredek pro inhalaci
AU68250/00A AU6825000A (en) 1999-07-23 2000-07-20 Formulations of steroid solutions for inhalatory administration
HU0201956A HUP0201956A3 (en) 1999-07-23 2000-07-20 Formulations of steroid solutions for inhalatory administration and process for their preparation
NO20020342A NO20020342L (no) 1999-07-23 2002-01-22 Formuleringer av steroidlösninger for inhalasjonsadministrasjon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001625A IT1313553B1 (it) 1999-07-23 1999-07-23 Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.

Publications (3)

Publication Number Publication Date
ITMI991625A0 true ITMI991625A0 (it) 1999-07-23
ITMI991625A1 ITMI991625A1 (it) 2001-01-23
IT1313553B1 IT1313553B1 (it) 2002-09-09

Family

ID=11383393

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI001625A IT1313553B1 (it) 1999-07-23 1999-07-23 Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.

Country Status (14)

Country Link
US (1) US6967017B1 (it)
EP (1) EP1198224B1 (it)
AT (1) ATE241959T1 (it)
AU (1) AU6825000A (it)
CZ (1) CZ299071B6 (it)
DE (1) DE60003183T2 (it)
DK (1) DK1198224T3 (it)
ES (1) ES2200913T3 (it)
HU (1) HUP0201956A3 (it)
IT (1) IT1313553B1 (it)
NO (1) NO20020342L (it)
PL (1) PL198817B1 (it)
PT (1) PT1198224E (it)
WO (1) WO2001007014A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010614A1 (it) * 2001-10-16 2003-04-16 Italchimici S P A Preparazione farmaceutica di una soluzione idro/propilenica di budesonide e suo procedimento di preparazione.
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
ITMI20032054A1 (it) 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
ITRM20040268A1 (it) * 2004-05-31 2004-08-31 Italchimici S P A Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione.
UA92732C2 (ru) 2005-02-25 2010-12-10 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Фармацевтические аэрозольные композиции для ингаляторов под давлением с вымеренными дозами, которые содержат связующее соединение
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation
CZ302596B6 (cs) * 2007-04-12 2011-07-27 Jihoceská univerzita v Ceských Budejovicích, Zemedelská fakulta Zpusob zpracování biomasy jetele lucního

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361306A (en) 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
US3622053A (en) 1969-12-10 1971-11-23 Schering Corp Aerosol inhaler with flip-up nozzle
MX3864E (es) 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
US4185100A (en) 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4499108A (en) 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
IT1196142B (it) 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US5192528A (en) 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
WO1992011236A1 (en) 1990-12-19 1992-07-09 Smithkline Beecham Corporation Aerosol formulations
US6006745A (en) 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE69227189T2 (de) 1991-05-21 1999-02-25 Abbott Laboratories, Abbott Park, Ill. Aerosolinhalationsvorrichtung
DE59209686D1 (de) 1991-08-29 1999-06-02 Broncho Air Medizintechnik Ag Medizinisches gerät zur inhalation von dosier-aerosolen
NZ244439A (en) 1991-09-25 1994-01-26 Fisons Plc Pressurised aerosol compositions comprising hydrofluoroalkane, dispersed
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
CA2126244C (en) 1991-12-18 2000-09-26 Robert K. Schultz Suspension aerosol formulations
DE4230876A1 (de) 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
RO117414B1 (ro) 1992-12-09 2002-03-29 Jager Paul D Waterbury Compozitie farmaceutica de aerosol in solutie
SE9203743D0 (sv) 1992-12-11 1992-12-11 Astra Ab Efficient use
WO1994014490A1 (de) 1992-12-23 1994-07-07 Bernhard Hugemann Verfestigter arzneistoffvorrat für die mechanische erzeugung inhalierbarer wirkstoffpartikel
ES2122261T3 (es) 1993-03-17 1998-12-16 Minnesota Mining & Mfg Formulacion de aerosol que contiene un adyuvante de dispersion derivado de un ester, una amida o un mercaptoester.
US6042811A (en) 1993-03-17 2000-03-28 3M Innovative Properties Company Aerosol formulation containing a diol-diacid derived dispersing aid
US6596260B1 (en) 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
ES2145254T3 (es) 1993-12-20 2000-07-01 Minnesota Mining & Mfg Formulaciones de aerosoles que contienen flunisolida.
GB9425160D0 (en) 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
MY131733A (en) 1994-12-22 2007-08-30 Astra Ab Aerosol drug formulations
GB9426252D0 (en) 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
US5653961A (en) 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
RO119116B1 (ro) 1995-04-14 2004-04-30 Glaxo Wellcome Inc. Inhalator pentru dozarea salmeterolului
AP791A (en) 1995-04-14 1999-12-17 Glaxo Wellcome Inc Metered dose inhaler for albuterol.
SK139197A3 (en) 1995-04-14 1998-04-08 Glaxo Wellcome Inc Metered dose inhaler for beclomethasone dipropionate
EP1769819A3 (en) 1995-04-14 2013-05-22 GlaxoSmithKline LLC Metered dose inhaler for fluticasone propionate
GB9612297D0 (en) 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
WO1998001147A1 (en) 1996-07-08 1998-01-15 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
WO1998003533A1 (en) 1996-07-24 1998-01-29 Oligos Etc. And Oligos Therapeutics, Inc. Antisense oligonucleotides as antibacterial agents
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9620187D0 (en) 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
JP2001505171A (ja) 1996-12-04 2001-04-17 バイオグラン アイルランド（アール アンド ディ）リミテッド 製薬組成物及びその投与のための装置
JP2001511160A (ja) 1997-02-05 2001-08-07 ヤゴ リサーチ アクチェンゲゼルシャフト 医学用エアゾール配合物
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US5891419A (en) 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
BR7702049U (pt) 1997-09-05 1999-09-14 Chiesi Farma Spa Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
US5954047A (en) 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
US6045784A (en) 1998-05-07 2000-04-04 The Procter & Gamble Company Aerosol package compositions containing fluorinated hydrocarbon propellants
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
BR9911351A (pt) 1998-06-18 2001-03-13 Boehringer Ingelheim Pharma Formulações farmacêuticas para aerossóis com duas ou mais substâncias ativas
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
ES2234266T3 (es) 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
DK1102579T3 (da) 1998-08-04 2003-07-14 Jago Res Ag Medicinske aerosolformuleringer
SI1121112T1 (sl) 1998-10-17 2002-10-31 Boehringer Ingelheim Pharma Kg Uskladiščljiv koncentrat aktivne snovi s formoterolom
DE19847969A1 (de) 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
DK1283036T3 (da) 1998-11-13 2008-03-25 Jagotec Ag Törpulver til inhalation
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
SK286981B6 (sk) 1999-03-05 2009-08-06 Chiesi Farmaceutici S.P.A. Prášok na použitie v inhalátore na suché prášky, nosič na tento prášok a spôsob výroby prášku
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
DE60019167T2 (de) 1999-12-24 2006-05-11 Glaxo Group Ltd., Greenford Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
CA2411047C (en) 2000-05-22 2009-08-04 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers

Also Published As

Publication number Publication date
NO20020342D0 (no) 2002-01-22
DK1198224T3 (da) 2003-09-29
CZ2002257A3 (cs) 2002-05-15
IT1313553B1 (it) 2002-09-09
US6967017B1 (en) 2005-11-22
ITMI991625A1 (it) 2001-01-23
HUP0201956A2 (en) 2002-10-28
PT1198224E (pt) 2003-10-31
NO20020342L (no) 2002-01-22
AU6825000A (en) 2001-02-13
WO2001007014A1 (en) 2001-02-01
HUP0201956A3 (en) 2003-10-28
CZ299071B6 (cs) 2008-04-16
PL353470A1 (en) 2003-11-17
EP1198224A1 (en) 2002-04-24
ATE241959T1 (de) 2003-06-15
PL198817B1 (pl) 2008-07-31
DE60003183D1 (de) 2003-07-10
ES2200913T3 (es) 2004-03-16
DE60003183T2 (de) 2004-04-29
EP1198224B1 (en) 2003-06-04

Similar Documents

Publication Publication Date Title
PT1410791E (pt) Forma galénica apta a ser administrada oralmente compreendendo metformina e um agente promotor da absorção
EE200100010A (et) Kinoliini derivaadid, nende kasutamine ravimina, neid sisaldavad farmatseutilised kompositsioonid ning ühendite ja farmatseutiliste kompositsioonide kasutamine patoloogilisest põletikust ja autoimmuunsusest tingitud haiguste ravis
HUP0203437A3 (en) Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases
EP1191933A4 (en) NASAL ADMINISTRATION OF APOMORPHINE
ATE413188T1 (de) Menschliche papillomavirus impfstoff- formulierungen
ID29468A (id) Komposisi farmasi yang stabil dalam bentuk liofil
EE200000484A (et) Täiustused ravimi väljastusseadmetele
DK1156777T3 (da) Præparat til oral administration til inhibering af dårlig ånde
AU6634400A (en) Dose of an angiogenic factor and method of administering to improve myocardial blood flow
HUP0002512A3 (en) Medicinal compositions for application to mucosa
EE200100007A (et) Kinoliini derivaadid, nende kasutamine ravimina, neid sisaldavad farmatseutilised kompositsioonid ning ühendite ja farmatseutiliste kompositsioonide kasutamine patoloogilisest põletikust ja autoimmuunsusest tingitud haiguste ravis
AU6372900A (en) Linkage of agents to tissue
ID28675A (id) Komposisi dosis oral pelepasan diperpanjang yang stabil
NO20020185L (no) Formuleringer av IL-11
EE200200075A (et) Peroraalselt ja paikselt manustatavad farmatseutilised kompositsioonid
PT1240157E (pt) Derivados substituidos do acido n-benzil-indol-3-il-glioxalico com efeito antitumoral
ITMI991625A0 (it) Formulazioni ottimizzate costituite da soluzioni di steroidi da sommin istrare per inalazione
HUP0203303A3 (en) Compositions for administering taxanes orally to human patients
NO20021898L (no) Farmasoytisk sammensetning inneholdende ciclesonid for applikasjon til mukosa
NO20011103D0 (no) Lokal avlevering av legemidler til hjertet
ITMI20011446A0 (it) Composizioni farmaceutiche di principi attivi suscettibili di somministrazione illecita
NO20003799D0 (no) Innkorporering av kolesterol-senkende midler i konfektdosisformer
GB0026923D0 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
ATE371446T1 (de) Zusammensetzungen zur verhinderung der adhäsion
GB9924766D0 (en) New use of acetyl salicilic acid